Lexicon Pharmaceuticals, Inc. (LXRX)
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
$2.32-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+116.8%
The outlook
Lexicon Pharmaceuticals, Inc. currently reads as bullish based on buy — 2.0 avg of 5 analysts, above its 50- & 200-day averages, 79% of the way from its 52-week low to high, avg target +63% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Price targetAvg target +63% vs current price
Analyst price target
~12-month · 5 analysts$3.77average target+62.5% vs now
Now $2.32
Low $1.75High $6.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.03B
52-wk high
$2.68
52-wk low
$1.00
50-day avg
$2.17
200-day avg
$1.66
Trailing P/E
—